
Co-Diagnostics Inc Investor Relations Material
Latest events

Q1 2025
Co-Diagnostics Inc
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Co-Diagnostics Inc
Access all reports
Co-Diagnostics, Inc. is a molecular diagnostics company that develops and manufactures diagnostic testing products. The company's core focus is on creating and commercializing molecular technologies that detect infectious diseases, as well as other genetic conditions. Co-Diagnostics utilizes its proprietary CoPrimer technology to design highly accurate and cost-effective diagnostic tests. The company serves the healthcare sector, offering its products to laboratories, hospitals, and healthcare providers globally, with applications in human diagnostics, agriculture, and animal testing. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
CODX
Country
🇺🇸 United States